Search company, investor...

The profile is currenly unclaimed by the seller. All information is provided by CB Insights.

Founded Year



Seed | Alive

Total Raised


Last Raised

$4M | 2 yrs ago

About Embryonics

Embryonics develops AI algorithms to optimize and improve the patient experience and the success of IVF.

Embryonics Headquarters Location

12 Haumanim St.

Tel Aviv, 6789731,


Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Research containing Embryonics

Get data-driven expert analysis from the CB Insights Intelligence Unit.

CB Insights Intelligence Analysts have mentioned Embryonics in 1 CB Insights research brief, most recently on Sep 19, 2022.

Expert Collections containing Embryonics

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Embryonics is included in 3 Expert Collections, including Digital Health.


Digital Health

21,952 items

Startups recreating how healthcare is delivered


Women's Health & Wellness

1,476 items

Startups focused on providing products and services catering to women's health and wellbeing.


Artificial Intelligence

9,391 items

This collection includes startups selling AI SaaS, using AI algorithms to develop their core products, and those developing hardware to support AI workloads.

Embryonics Patents

Embryonics has filed 2 patents.

The 3 most popular patent topics include:

  • Artificial intelligence
  • Artificial neural networks
  • Assisted reproductive technology
patents chart

Application Date

Grant Date


Related Topics



Artificial neural networks, Fertility medicine, Artificial intelligence, Assisted reproductive technology, Machine learning


Application Date


Grant Date


Related Topics

Artificial neural networks, Fertility medicine, Artificial intelligence, Assisted reproductive technology, Machine learning



Latest Embryonics News

Roundup: Docty setting up 100 telehealth kiosks in India and more briefs

Apr 22, 2022

Also, IVF clinic FertilTree is adopting an AI assistive tool for embryo selection by Embryonics. Docty targets to set up 100 telehealth kiosks in three Indian states Telehealth firm Docty has disclosed its plan to open 100 digital health kiosks across the states of Telangana, Andhra Pradesh, and Maharashtra over the next six months. The company aims to improve healthcare access in rural and impoverished urban communities through its Gali Gali Mein Digital Clinic initiative, which currently operates in over 20 locations. Aiming to launch in 100 more sites, Docty has partnered with over a hundred offline stores, local pharmacies, photo-copy centres, and internet cafes to launch its kiosks where patients can access online consultations with doctors and receive prescriptions. The kiosks also offer discounted medicines and lab services. According to a news report , its strategy is to set up its kiosks every three kilometres in cities and five km. in villages, targetting high-density areas. Rural India currently lacks qualified professionals, digital infrastructure, and technology literacy to support digital health, according to Docty co-founder Ramya Subramanian. In order to deliver the benefits of digital health to people living in such areas, Docty has acknowledged the need to establish local support centres through a one-stop integrated platform. "Additionally, Docty’s digital health kiosks will also be significant in reducing digital illiteracy in India," Subramanian added. By next year, Docty aims to further expand its digital health kiosks in three more states, Tamil Nadu, Uttar Pradesh, and Bihar. It has an ambitious target of reaching 65% of the Indian population by 2025. IVF clinic FertilTree adopts Embryonics' AI tool for embryo selection FertilTree-Jaslok International Fertility Centre, a fertility clinic based in Mumbai, India, has partnered with Israeli firm Embryonics to adopt its AI assistive tool for embryo selection. Embryonics' UBAR assists embryologists in a highly subjective decision-making step in the IVF process. It is a cloud-based software that uses time-lapse videos or single images of blastocysts to predict implantation probability. Its algorithms are trained using a large, multicentre dataset sourced from the US, Israel, Europe, and Asia. According to a press statement, their partnership aims to help raise the success rate of fertility treatments in India. "Algorithms created by AI and deep machine learning detect signals from developing embryos most likely to result in babies. These include healthy and equal division of embryonic cells," noted Dr Firuza Parikh, head of FertilTree. She said they have already conducted an interim analysis using UBAR and have computed a predictive score most likely to result in a pregnancy. "This method is simple and inexpensive," she claimed. Paytm enables national health ID creation with ABHA integration Paytm, a fintech platform run by One97 Communications in India, is the latest tech provider to partner with the National Health Authority's Ayushman Bharat Digital Mission. The e-commerce and payment app now enables its users to create their unique Ayushman Bharat Health Account (ABHA) number, which they can use to access and share their health data with healthcare providers. In other news, Paytm recently launched an online health store on its platform where various health and insurance providers offer healthcare products and services. Topics:

Embryonics Web Traffic

Page Views per User (PVPU)
Page Views per Million (PVPM)
Reach per Million (RPM)
CBI Logo

Embryonics Rank

  • When was Embryonics founded?

    Embryonics was founded in 2018.

  • Where is Embryonics's headquarters?

    Embryonics's headquarters is located at 12 Haumanim St., Tel Aviv.

  • What is Embryonics's latest funding round?

    Embryonics's latest funding round is Seed.

  • How much did Embryonics raise?

    Embryonics raised a total of $4M.

  • Who are the investors of Embryonics?

    Investors of Embryonics include Israel Innovation Authority, Charles and Lynn Schusterman Family Foundation and Google for Startups Accelerator.

  • Who are Embryonics's competitors?

    Competitors of Embryonics include Presagen and 1 more.

You May Also Like

Alife Health

Alife Health, a technology company founded in 2020, is building AI tools designed to improve fertility care, starting with in vitro fertilization (IVF).

Automation Anywhere Logo
Automation Anywhere

Automation Anywhere is a cognitive robotic process automation platform that uses software robots to automate business processes not automated by traditional technology platforms. Its Intelligent Digital Workforce Platform combines cognitive automation and analytics, driving productivity and business process accuracy with near-zero error rates.

Owkin Logo

Owkin specializes in AI technologies applied to clinical research with the aim of developing better drugs and treatments for patients. The company's purpose is to empower researchers in hospitals, universities and the biopharma industry to i) understand why drug efficacy varies from patient to patient, ii) improve the drug development process and iii) to help identify key drugs and treatments for each individual patient to improve patient outcomes. The company's precision medicine platform aims to enable medical insights for drug discovery and development by connecting life sciences firms with academic researchers and hospitals. The Owkin platform aims to enable partners to uncover siloed datasets while maintaining patient privacy and securing proprietary data using Federated Learning and innovative collaborative AI technology. The company was founded in 2016 and is based in New York, New York.

Maven Clinic

Maven is a digital health clinic for women. The company's mobile app gives users access to instant video appointments and private messaging with healthcare practitioners, anywhere and anytime.


Mojo makes assisted reproduction more accurate, affordable and accessible for aspiring parents worldwide, using AI and robotics technology.

Kindbody Logo

Kindbody is a fertility and family-building benefits provider for employers offering virtual and in-person care. Kindbody contracts directly with employers, solving for the fragmentation of care that members undergo in their reproductive health journey, offering fertility services supported by full-spectrum gynecology and pre and postpartum services under one roof. As an in-network provider, Kindbody is uniquely positioned to integrate with the client's major medical plans and run a fertility benefit seamlessly. Kindbody was founded in 2018 and is based in New York, New York.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.